Are We Closer to Personalized Medicine in MS?

Disclaimers

Program Goals

What Is Personalized Medicine?

What Is Personalized Medicine? (cont)

Prognostic Indicators

Biomarkers: JC Virus Antibody Index

Biomarkers

Patient Factors

Drug Factors

Assessing Risk

Experience With MS Drugs: Clinical Practice vs Clinical Trials

Monitoring Response

Monitoring Response: Modified Rio Score

Monitoring Response (cont)

Switching and Sequencing Therapy

Risk Stratification at Diagnosis -- and Beyond

On the Horizon: Agents in Development

On the Horizon: Reduced Injections

Summary and Key Points

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)